Table 2. Efficacy of oral miltefosine on 27 patients with acute anthroponotic cutaneous leishmaniasis.

Variable	Base line	Treatment		Follow up
		14 days	28 days	3 month	6 month	12 month
Lesion size (Cm)	2.38 ± 0.73	1.31 ± 0.59	0.61 ± 0.23	0.26 ± 0.12	0.21 ± 0.08	0.03 ± 0.01
Definite patient cure* (number)	-	0	0	14	17	17
Partial patient cure**/No cure*** (number)	-/-	9/18	19/8	9/2 (clinical failure)	5/2 (clinical failure)	5/2 (clinical failure)

*Patients with complete response in all the lesions according to induration and skin smear test.

**Patients with lesion(s) more than 50% improvement but not complete response.

***Patients with lesion(s) less than 50% improvement according to induration size.